Cell Salts

Product NDC

55714-2402

Requested package NDC

55714-2402-1

11-digit product format

557142402

Labeler code

55714

Product ID

55714-2402_3ab3dca6-2bec-3613-e063-6394a90acad6

Type

HUMAN OTC DRUG

Nonproprietary name

Calc. fluor., Calc. phos., Calc.sulph., Ferrum phosphoricum, Kali mur., Kali phos., Kali sulph., Mag. phos., Nat. mur., Nat. phos., Nat.sulphuricum, Silicea

Dosage form

LIQUID

Route

ORAL

Labeler

Newton Laboratories, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2018-11-07

Substance

CALCIUM FLUORIDE; TRIBASIC CALCIUM PHOSPHATE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SILICON DIOXIDE

Active strength

10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Pharmacologic classes

Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

NDC exclude flag

No

Listing certified through

2026-12-31

Current FDA listing

Yes